MHS gets bad news; Big pharma seeks to deal with approaching patent cliff;

> The second Medicare Health Support report has been delivered to Congress, and the news is not good: the program didn't achieve much improvement, while costing more than it saved. PDF

> Big pharma is taking a varied approach to dealing with the large number of patents that will expire in 2011. FiercePharma

> A new test can look at the genetic code of a hepatitis C variant and tell doctors whether the patient will respond to available drugs. FierceBioResearcher

> Some California health foundations and think tanks are turning themselves into lobbyists to try to finally get results in healthcare reform. Article

And Finally... This philosophy competition asks tough questions. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.